Clinical trial
Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung Cancer
NCT00041314
Study timeline
Study start (actual)2002-10-04Date precision: day
Registry last updated2023-06-15
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Lung Cancerunresolved
Interventions
carboplatinDRUG · verified · RxNorm: carboplatin
exisulindDRUG
gemcitabine hydrochlorideDRUG · verified · RxNorm: gemcitabine hydrochloride
Sponsors & collaborators
Eastern Cooperative Oncology Grouplead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
PhiladelphiaPennsylvania, United States3New YorkNew York, United States2BostonMassachusetts, United States2ChicagoIllinois, United States2NashvilleTennessee, United States2ClevelandOhio, United States2PittsburghPennsylvania, United States2TampaFlorida, United States2IndianapolisIndiana, United States2MinneapolisMinnesota, United States2OmahaNebraska, United States2The BronxNew York, United States2
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00041314 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.